-
Recently, CareCredit, part of Synchrony Financial, announced a partnership with Vetspire to embed CareCredit financing into Vetspire’s AI-enabled veterinary practice management platform, while Synchrony also released its 2026 AI in Commerce study with Oxford Economics highlighting consumer priorities around security, transparency, and fraud protection in AI-driven shopping.
-
Together, these moves underline Synchrony’s push to embed financing directly into specialized healthcare workflows and future AI shopping journeys, aligning its offerings more closely with how consumers and businesses actually manage payments.
-
Against this backdrop, we’ll explore how embedding CareCredit into Vetspire’s platform could influence Synchrony Financial’s investment narrative around AI-enabled, point-of-care financing.
Outshine the giants: these 18 early-stage AI stocks could fund your retirement.
Synchrony Financial Investment Narrative Recap
To own Synchrony Financial, you need to believe it can grow receivables and fee income by deepening digital, embedded-finance partnerships while keeping credit costs under control. The CareCredit Vetspire integration and AI in Commerce work may support the near term catalyst around expanding health and pet financing, but do not materially change the key risk that tighter credit and selective consumer spending could still weigh on purchase volumes and net revenue.
The Vetspire partnership looks most relevant here because it extends Synchrony’s push into high growth health and pet care verticals using embedded, AI-enabled workflows at the point of care. That sits directly against current concerns about flat or declining loan receivables, since broader CareCredit usage in veterinary practices could help offset softer volumes elsewhere if it scales effectively.
Yet while this AI enabled growth story is appealing, investors should also be aware that rising tech spend and regulatory pressure could still compress margins if…
Read the full narrative on Synchrony Financial (it’s free!)
Synchrony Financial’s narrative projects $16.6 billion revenue and $3.0 billion earnings by 2029. This requires 18.9% yearly revenue growth and a $0.5 billion earnings decrease from $3.5 billion today.
Uncover how Synchrony Financial’s forecasts yield a $89.22 fair value, a 24% upside to its current price.
Exploring Other Perspectives
Some of the lowest estimate analysts take a much more cautious view, assuming revenues of about US$17.1 billion and earnings near US$2.9 billion, so you should weigh this more pessimistic margin and credit cycle narrative against the new AI commerce and CareCredit integrations and decide which scenario feels closer to how you see Synchrony’s next few years playing out.
